(Q51392451)

4 April 2018

title

Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: a case-control study. (English)

1 reference

4 April 2018

1 reference

1 reference

6

1 reference

4 April 2018

Douglas Kondziolka

9

object named as

Douglas Kondziolka

1 reference

4 April 2018

Kyung-Jae Park

1

1 reference

4 April 2018

Hideyuki Kano

2

1 reference

4 April 2018

Aditya Iyer

3

1 reference

4 April 2018

Xiaomin Liu

4

1 reference

4 April 2018

Ajay Niranjan

5

1 reference

4 April 2018

Frank S Lieberman

7

1 reference

4 April 2018

L Dade Lunsford

8

1 reference

4 April 2018

publication date

5 November 2011

1 reference

4 April 2018

Journal of Neuro-Oncology

published in

1 reference

4 April 2018

volume

107

1 reference

4 April 2018

issue

2

1 reference

4 April 2018

page(s)

323-333

1 reference

4 April 2018

https://scigraph.springernature.com/pub.10.1007/s11060-011-0744-9

exact match

0 references

cites work

Stereotactic radiosurgery for glioblastoma: retrospective analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

VEGF as a therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Clinical implications of circulating angiogenic factors in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Reirradiation of primary CNS tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Reirradiation tolerance of the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Phase II study of high central dose Gamma Knife radiosurgery and marimastat in patients with recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Taming glioblastoma: targeting angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Autocrine pathways of the vascular endothelial growth factor (VEGF) in glioblastoma multiforme: clinical relevance of radiation-induced increase of VEGF levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Design of clinical trials of radiation combined with antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Radiation-enhanced vascular endothelial growth factor (VEGF) secretion in glioblastoma multiforme cell lines--a clue to radioresistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

VEGF trap in combination with radiotherapy improves tumor control in u87 glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Current status of angiogenesis inhibitors combined with radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Stereotactic radiosurgery for recurrent malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Case-control study of stereotactic radiosurgery for recurrent glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Gamma Knife radiosurgery after radiation therapy as an adjunctive treatment for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Effect of bevacizumab on radiation necrosis of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Isolation and characterization of human malignant glioma cells from histologically normal brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0744-9

Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme

21 January 2018

1 reference

12 December 2020

Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.

1 reference

12 December 2020

Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas

1 reference

12 December 2020

Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme

1 reference

12 December 2020

Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation

1 reference

12 December 2020

10.1007/S11060-011-0744-9

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018